ESC 365 - Is a breakthrough treatment for patients with HFpEF within reach?

ESC Premium Access

Is a breakthrough treatment for patients with HFpEF within reach?

Session: Treating patients with HFpEF: what progress are we making?

Topic: Treatment

Speaker: Professor S. Solomon (Boston, US)

Sponsored by Novartis Pharma AG

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

73 presentations

28 followers

4 more presentations in this session

Welcome and introduction

Speaker: Professor C. Lam (Singapore, SG)

Is HFpEF the largest unmet need in cardiology?

Speaker: Professor J. McMurray (Glasgow, GB)

Discussions, questions and answers

Speaker: Professor C. Lam (Singapore, SG) Professor J. McMurray (Glasgow, GB) Professor S. Solomon (Boston, US)

Key learnings and close

Speaker: Professor C. Lam (Singapore, SG)

Access the full session

Treating patients with HFpEF: what progress are we making?

Speakers: Professor S. Solomon, Professor C. Lam, Professor J. McMurray, Professor C. Lam, Professor J. McMurray...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources